• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特定血清素再摄取抑制剂或氯米帕明与抗焦虑/睡眠药物联合使用的药物利用审查。

Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications.

作者信息

Rascati K

机构信息

College of Pharmacy, Division of Pharmacy Administration, University of Texas at Austin, USA.

出版信息

Clin Ther. 1995 Jul-Aug;17(4):786-90. doi: 10.1016/0149-2918(95)80055-7.

DOI:10.1016/0149-2918(95)80055-7
PMID:8565041
Abstract

Side effects of some antidepressants include anxiety and insomnia. A retrospective drug utilization review was conducted to determine the amount of concurrent use of an antidepressant with medication that may counteract these side effects. Texas Medicaid claims data for 1993 included more than 30,000 patients receiving a specific serotonin reuptake inhibitor (SSRI) or clomipramine. A total of 35.0% of these patients were also taking a medication that could be used to relieve anxiety or induce sleep, and 15.2% of the total were receiving once-daily dosing of the latter type of medication. Concomitant use of SSRIs or clomipramine with trazodone occurred in 7.7% of the patients.

摘要

一些抗抑郁药的副作用包括焦虑和失眠。开展了一项回顾性药物利用审查,以确定抗抑郁药与可能抵消这些副作用的药物同时使用的情况。1993年得克萨斯州医疗补助索赔数据涵盖了3万多名正在服用特定血清素再摄取抑制剂(SSRI)或氯米帕明的患者。这些患者中共有35.0%还在服用可用于缓解焦虑或诱导睡眠的药物,且总计15.2%的患者接受了后者这类药物的每日一次给药。7.7%的患者同时使用了SSRI或氯米帕明与曲唑酮。

相似文献

1
Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications.特定血清素再摄取抑制剂或氯米帕明与抗焦虑/睡眠药物联合使用的药物利用审查。
Clin Ther. 1995 Jul-Aug;17(4):786-90. doi: 10.1016/0149-2918(95)80055-7.
2
Concomitant use of anxiolytics and hypnotics with selective serotonin reuptake inhibitors.抗焦虑药和催眠药与选择性5-羟色胺再摄取抑制剂的联合使用。
Clin Ther. 1996 May-Jun;18(3):521-7; discussion 520. doi: 10.1016/s0149-2918(96)80034-8.
3
Other Antidepressants.其他抗抑郁药。
Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167.
4
Increased rate of trazodone prescribing with bupropion and selective serotonin-reuptake inhibitors versus tricyclic antidepressants.与三环类抗抑郁药相比,安非他酮和选择性5-羟色胺再摄取抑制剂联用曲唑酮的处方率增加。
Ann Pharmacother. 2000 Sep;34(9):1007-12. doi: 10.1345/aph.19101.
5
Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.治疗儿科焦虑症:SSRIs 和其他抗焦虑处方药的初步使用。
J Clin Psychiatry. 2018 Jan-Feb;79(1). doi: 10.4088/JCP.16m11415.
6
A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.选择性5-羟色胺再摄取抑制剂治疗强迫症的疗效综述。
J Clin Psychiatry. 1999 Feb;60(2):101-6. doi: 10.4088/jcp.v60n0206.
7
Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.氯米帕明与选择性5-羟色胺再摄取抑制剂联合治疗儿童和青少年强迫症
J Child Adolesc Psychopharmacol. 1998;8(1):61-7. doi: 10.1089/cap.1998.8.61.
8
Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.帕罗西汀:在治疗惊恐障碍中的药理学和治疗潜力的综述。
CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.
9
Augmenting selective serotonin reuptake inhibitors with clomipramine in obsessive-compulsive disorder: benefits and risks.在强迫症中,用氯米帕明增强选择性 5-羟色胺再摄取抑制剂的疗效:获益与风险。
J Clin Psychiatry. 2013 Dec;74(12):e1128-33. doi: 10.4088/JCP.13f08883.
10
Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.医疗补助参保青少年中抗抑郁药物与2型糖尿病发病的关联
JAMA Pediatr. 2017 Dec 1;171(12):1200-1207. doi: 10.1001/jamapediatrics.2017.2896.

引用本文的文献

1
Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.褪黑素治疗可纠正慢性持续光照暴露大鼠主观光照期睡眠-觉醒周期和睡眠结构的损害,并增加海马 MT 受体和 BDNF 的表达。
Psychopharmacology (Berl). 2020 Feb;237(2):503-518. doi: 10.1007/s00213-019-05385-y. Epub 2019 Nov 13.
2
Correlates of Psychotropic Polypharmacy in outpatient psychiatric clinics of two military tertiary hospitals in Saudi Arabia.沙特阿拉伯两家军队三级医院门诊精神科中精神药物联合使用的相关因素
J Family Community Med. 2019 Sep-Dec;26(3):213-220. doi: 10.4103/jfcm.JFCM_31_19.
3
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
使用回顾性索赔数据分析重度抑郁症中品牌药和仿制药的治疗模式及持续性。
Neuropsychiatr Dis Treat. 2016 Oct 25;12:2755-2764. doi: 10.2147/NDT.S115094. eCollection 2016.
4
Risk factors for non-adherence to antidepressant treatment in patients with mood disorders.心境障碍患者抗抑郁药治疗依从性差的危险因素。
Eur J Clin Pharmacol. 2014 Jan;70(1):89-98. doi: 10.1007/s00228-013-1582-9. Epub 2013 Sep 8.
5
Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review.重度抑郁症中睡眠和警觉性障碍的临床相关性:一项综述
Prim Care Companion J Clin Psychiatry. 2010;12(6). doi: 10.4088/PCC.08m00676gry.
6
Circadian rhythm disturbances in depression.抑郁症中的昼夜节律紊乱。
Hum Psychopharmacol. 2008 Oct;23(7):571-85. doi: 10.1002/hup.964.
7
[Sleep disorders in depression. Suggestions for a therapeutic approach].[抑郁症中的睡眠障碍。治疗方法建议]
Nervenarzt. 2007 Jan;78(1):21-30. doi: 10.1007/s00115-006-2111-1.
8
Polypharmacy in psychiatric practice in the Canary Islands.加那利群岛精神病学实践中的多重用药情况。
BMC Psychiatry. 2004 Jul 5;4:18. doi: 10.1186/1471-244X-4-18.
9
Clinically important drug interactions with zopiclone, zolpidem and zaleplon.与佐匹克隆、唑吡坦和扎来普隆具有临床重要意义的药物相互作用。
CNS Drugs. 2003;17(7):513-32. doi: 10.2165/00023210-200317070-00004.
10
Fluoxetine. A pharmacoeconomic review of its use in depression.氟西汀。对其用于治疗抑郁症的药物经济学综述。
Pharmacoeconomics. 1998 May;13(5 Pt 1):543-61. doi: 10.2165/00019053-199813050-00007.